Optimizing Oncology Clinical Trials

CancerLinQ has developed a comprehensive solution to improve access to clinical trials for all patients with cancer, as well as increase recruitment and success rates for research studies. Using an integrated approach powered by next-generation AI, TriaLinQ facilitates clinical research for patients in CancerLinQ practices for observational and interventional trials.

Learn More

Powered by Automation

TriaLinQ is powered by the near real-time connection to the electronic health record (EHR) and secondary source systems of practices in the CancerLinQ network, providing the capability to automatically identify practice patients, using technology to enable patient recruitment.

Increasing Access

TriaLinQ is designed to support oncology clinical trials conducted in diverse patient populations, including those historically underrepresented in clinical investigations, across CancerLinQ’s growing network of community oncology practices and cancer centers.